Sara Bailey

Executive · Director, Office of National Drug Control Policy · Office of National Drug Control Policy

Sara Bailey is Director, Office of National Drug Control Policy. Senior officials of the executive branch file their securities transactions with the Office of Government Ethics rather than with Congress. We hold 5 disclosed purchases and sales filed since 11 June 2026, 5 of them in the last 90 days.

AgencyOffice of National Drug Control Policy
Disclosed buys and sells5 in all, 5 in the last 90 days
Last disclosure11 June 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 18 September 2025 — 11 June 2026Director · Office of National Drug Control Policy4 reports filed with the Office of Government Ethics · source: Office of Government Ethics

Everything they disclosed

1 entry, newest first — one per disclosure report, one per Form 4 line

bought GE Verona, Fidelity Advisor Biotechnology Fund Class C Shares (FBTCX), TMC the metals company and 1 more; sold TMC the metals companyOffice of Government Ethics11 June 2026$1,001–$15,000 · traded 1 Feb – 1 Mar, filed 11 Jun · 5 transactions in this report

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.